Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Nina Chu"'
Autor:
Kevin Schifferli, Gordon Moody, Karma Dacosta, Nina Chu, Ryan Gilbreth, Lori Clarke, Christina Gesse, Letizia Giardino, Cui Chen, Erin Sult, Noel Monks, Ravinder Tammali, Jon Chesebrough, Jessica Tong, Xiao-Tao Yao, Kapil Vashisht
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/4c51e28240674a9e93fe3715949db0c1
Autor:
Lorraine Pelosof, Sashidhar Yerram, Todd Armstrong, Nina Chu, Ludmila Danilova, Breann Yanagisawa, Manuel Hidalgo, Nilofer Azad, James G. Herman
Publikováno v:
Epigenetics, Vol 12, Iss 7, Pp 540-550 (2017)
Epigenetic control of gene expression is a major determinant of tumor phenotype and has been found to influence sensitivity to individual chemotherapeutic agents. Glutathione peroxidase 3 (GPX3, plasma glutathione peroxidase) is a key component of ce
Externí odkaz:
https://doaj.org/article/ef0106233e1b4f0ead57cee02a0bc36a
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e112784 (2014)
In response to hypoxia and other stress, the sympathetic (adrenergic) nervous system regulates arterial contractility and blood flow, partly through differential activities of the alpha1 (α1) - adrenergic receptor (AR) subtypes (α1A-, α1B-, and α
Externí odkaz:
https://doaj.org/article/018ecbefc95443c295e096e5ddfc7d37
Autor:
Qi Zhang, Qihan Fu, Wanyue Cao, Xingyuan Xu, Ao Xia, Jiaqi Huang, Andy Zou, Judy Zhu, Fei Wang, Yi Hong, Hui Wan, Yihong Yao, Nina Chu, Ryan Gilbreth, Maria Letizia Giardino Torchia, John Stone, Attilio Bondanza, Benny Farsaci, Gordon Moody, Mark Cobbold, Tingbo Liang
Publikováno v:
Cancer Research. 83:CT097-CT097
Introduction: Chimeric antigen receptor (CAR) T cells can mediate deep and durable responses in hematologic malignancies, however, achieving success in solid tumors has been so far limited largely by lack of suitable solid tumor-associated antigens a
Autor:
Maria Letizia Giardino Torchia, Ryan Gilbreth, Ashley Merlino, Erin Sult, Noel Monks, Jon Chesebrough, Ravinder Tammali, Nina Chu, Jessica Tong, John Meekin, Kevin Schifferli, Kapil Vashisht, Karma DaCosta, Lori Clarke, Christina Gesse, Xiao-Tao Yao, Courtney Bridges, Gordon Moody
Publikováno v:
Cytotherapy. 24(7)
Chimeric antigen receptor (CAR) T cell therapy has yielded impressive clinical results in hematological malignancies and is a promising approach for solid tumor treatment. However, toxicity, including cytokine-release syndrome (CRS) and neurotoxicity
Autor:
Zhengyang Wang, Robert Huben, Peter B. Boucher, Chase Van Amburg, Jimmy Zeng, Nina Chung, Jocelyn Wang, Jeffrey King, Richard J. Knecht, Ivy Ng'iru, Augustine Baraza, Christopher C. M. Baker, Dino J. Martins, Naomi E. Pierce, Andrew B. Davies
Publikováno v:
Methods in Ecology and Evolution, Vol 15, Iss 5, Pp 978-993 (2024)
Abstract Ecologists, foresters and conservation practitioners need ‘biodiversity scanners’ to effectively inventory biodiversity, audit conservation progress and track changes in ecosystem function. Quantifying biological diversity using remote s
Externí odkaz:
https://doaj.org/article/231773adc9da4f66bc29a901053eb24e
Autor:
Lori A. Clarke, Michael G. Overstreet, Eric Tu, Christina Gesse, Nina Chu, Letizia Giardino, Gordon Moody, Ryan Gilbreth
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Chimeric antigen receptors (CARs) are engineered synthetic receptors that reprogram T cell specificity and function against a given antigen. Autologous CAR-T cell therapy has demonstrated potent efficacy against various hematological malig
Autor:
Nina Chu, Kevin Schifferli, Gordon Moody, Christina Gesse, Jon Chesebrough, Noel R. Monks, Letizia Giardino, Lori A. Clarke, Xiao-Tao Yao, Erin Sult, Kapil Vashisht, Karma Dacosta, Cui Chen, Jessica Tong, Ravinder Tammali, Ryan Gilbreth
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Chimeric antigen receptor (CAR)-T therapy has yielded impressive clinical results in hematological malignancies and it is a promising approach for solid tumor treatment. However, toxicity, including on-target off-tumor antigen binding, is
Autor:
Aleksandra Popovic, Nina Chu, Minwei Cao, Alexander Hopkins, Elana J. Fertig, Todd D. Armstrong, Robert A. Anders, Bridget P. Keenan, Jacquelyn W. Zimmerman, Elizabeth M. Jaffee
Publikováno v:
Cancer Prev Res (Phila)
Almost all pancreatic ductal adenocarcinomas (PDA) develop following KRAS activation, which triggers epithelial transformation and recruitment of desmoplastic stroma through additional transcriptional and epigenetic regulation, but only a few of thes
Autor:
Sashidhar R. Yerram, Breann Yanagisawa, Nina Chu, Todd D. Armstrong, Ludmila Danilova, Manuel Hidalgo, Lorraine Pelosof, Nilofer S. Azad, James G. Herman
Publikováno v:
Epigenetics. 12:540-550
Epigenetic control of gene expression is a major determinant of tumor phenotype and has been found to influence sensitivity to individual chemotherapeutic agents. Glutathione peroxidase 3 (GPX3, plasma glutathione peroxidase) is a key component of ce